COEP
Price
$11.91
Change
-$0.00 (-0.00%)
Updated
Jul 25 closing price
Capitalization
40.87M
NONOF
Price
$69.94
Change
-$0.13 (-0.19%)
Updated
Jul 25 closing price
Capitalization
313.33B
Interact to see
Advertisement

COEP vs NONOF

Header iconCOEP vs NONOF Comparison
Open Charts COEP vs NONOFBanner chart's image
Coeptis Therapeutics Holdings
Price$11.91
Change-$0.00 (-0.00%)
Volume$1.97K
Capitalization40.87M
Novo-Nordisk A/S
Price$69.94
Change-$0.13 (-0.19%)
Volume$25.34K
Capitalization313.33B
COEP vs NONOF Comparison Chart in %
Loading...
COEP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NONOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COEP vs. NONOF commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COEP is a StrongBuy and NONOF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2025
Stock price -- (COEP: $11.91 vs. NONOF: $69.94)
Brand notoriety: COEP and NONOF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COEP: 5% vs. NONOF: 46%
Market capitalization -- COEP: $40.87M vs. NONOF: $313.33B
COEP [@Biotechnology] is valued at $40.87M. NONOF’s [@Biotechnology] market capitalization is $313.33B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COEP’s FA Score shows that 0 FA rating(s) are green whileNONOF’s FA Score has 2 green FA rating(s).

  • COEP’s FA Score: 0 green, 5 red.
  • NONOF’s FA Score: 2 green, 3 red.
According to our system of comparison, NONOF is a better buy in the long-term than COEP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COEP’s TA Score shows that 6 TA indicator(s) are bullish while NONOF’s TA Score has 4 bullish TA indicator(s).

  • COEP’s TA Score: 6 bullish, 4 bearish.
  • NONOF’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, COEP is a better buy in the short-term than NONOF.

Price Growth

COEP (@Biotechnology) experienced а +11.52% price change this week, while NONOF (@Biotechnology) price change was +8.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NONOF($313B) has a higher market cap than COEP($40.9M). COEP YTD gains are higher at: 116.545 vs. NONOF (-18.577). NONOF has higher annual earnings (EBITDA): 147B vs. COEP (-9.95M). NONOF has more cash in the bank: 41.6B vs. COEP (4.27M). COEP has less debt than NONOF: COEP (2.04M) vs NONOF (119B). NONOF has higher revenues than COEP: NONOF (303B) vs COEP (62.9K).
COEPNONOFCOEP / NONOF
Capitalization40.9M313B0%
EBITDA-9.95M147B-0%
Gain YTD116.545-18.577-627%
P/E RatioN/A18.88-
Revenue62.9K303B0%
Total Cash4.27M41.6B0%
Total Debt2.04M119B0%
FUNDAMENTALS RATINGS
COEP vs NONOF: Fundamental Ratings
COEP
NONOF
OUTLOOK RATING
1..100
350
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
25
Undervalued
PROFIT vs RISK RATING
1..100
9367
SMR RATING
1..100
9914
PRICE GROWTH RATING
1..100
3762
P/E GROWTH RATING
1..100
10097
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NONOF's Valuation (25) in the null industry is somewhat better than the same rating for COEP (78). This means that NONOF’s stock grew somewhat faster than COEP’s over the last 12 months.

NONOF's Profit vs Risk Rating (67) in the null industry is in the same range as COEP (93). This means that NONOF’s stock grew similarly to COEP’s over the last 12 months.

NONOF's SMR Rating (14) in the null industry is significantly better than the same rating for COEP (99). This means that NONOF’s stock grew significantly faster than COEP’s over the last 12 months.

COEP's Price Growth Rating (37) in the null industry is in the same range as NONOF (62). This means that COEP’s stock grew similarly to NONOF’s over the last 12 months.

NONOF's P/E Growth Rating (97) in the null industry is in the same range as COEP (100). This means that NONOF’s stock grew similarly to COEP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COEPNONOF
RSI
ODDS (%)
Bearish Trend 3 days ago
47%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
48%
Bearish Trend 3 days ago
71%
Momentum
ODDS (%)
Bullish Trend 3 days ago
59%
Bullish Trend 3 days ago
81%
MACD
ODDS (%)
Bullish Trend 3 days ago
43%
Bullish Trend 3 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
45%
Bullish Trend 3 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
40%
Bearish Trend 3 days ago
72%
Advances
ODDS (%)
Bullish Trend 5 days ago
61%
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 7 days ago
60%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
44%
Bullish Trend 3 days ago
73%
Aroon
ODDS (%)
Bullish Trend 3 days ago
19%
Bearish Trend 3 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
COEP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NONOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PENG25.160.26
+1.04%
Penguin Solutions Inc
TGTX36.900.37
+1.01%
TG Therapeutics
PLD110.290.57
+0.52%
PROLOGIS
HFBL13.24N/A
N/A
Home Federal Bancorp
REFI13.46-0.08
-0.59%
Chicago Atlantic Real Estate Finance

COEP and

Correlation & Price change

A.I.dvisor indicates that over the last year, COEP has been loosely correlated with TVRD. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if COEP jumps, then TVRD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COEP
1D Price
Change %
COEP100%
N/A
TVRD - COEP
38%
Loosely correlated
-2.82%
QRON - COEP
36%
Loosely correlated
N/A
NRXP - COEP
27%
Poorly correlated
+0.33%
APLT - COEP
26%
Poorly correlated
-5.70%
PDSB - COEP
25%
Poorly correlated
-2.48%
More

NONOF and

Correlation & Price change

A.I.dvisor tells us that NONOF and ATNM have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NONOF and ATNM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NONOF
1D Price
Change %
NONOF100%
-0.19%
ATNM - NONOF
31%
Poorly correlated
-2.47%
NVO - NONOF
31%
Poorly correlated
+1.37%
LABFF - NONOF
23%
Poorly correlated
N/A
UCBJY - NONOF
21%
Poorly correlated
-0.14%
COEP - NONOF
14%
Poorly correlated
N/A
More